pO2 Polarography Versus Positron Emission Tomography ([18F] Fluoromisonidazole, [18F]-2-Fluoro-2’-Deoxyglucose)

@article{Gagel2004pO2PV,
  title={pO2 Polarography Versus Positron Emission Tomography ([18F] Fluoromisonidazole, [18F]-2-Fluoro-2’-Deoxyglucose)},
  author={Bernd Gagel and Patrick Reinartz and Ercole Dimartino and Michael Zimny and Michael Pinkawa and Payam Maneschi and Sven Stanzel and Kurt Hamacher and Heinz Hubert Coenen and Michael Westhofen and Ulrich Buell and Michael J. Eble},
  journal={Strahlentherapie und Onkologie},
  year={2004},
  volume={180},
  pages={616-622}
}
The aim of the present study was to validate ([18F] fluoromisonidazole (FMISO) and [18F]-2-fluoro-2’-deoxyglucose (FDG) positron emission tomography (PET) for determination of radiotherapeutically relevant hypoxia by the gold standard for measuring tissue oxygenation in human tumors, the computerized polarographic needle electrode system (pO2 histography). Up to now, a total of 16 patients with a metastatic neck lymph node from a primary squamous carcinoma of the head and neck underwent pO2 and… CONTINUE READING
23 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

18-F Fluordeoxyglukose PET beim Ovarialkarzinom: Methodik und erste Ergebnisse

  • M Zimny, W Schröder, S Wolters
  • Nuklearmedizin
  • 1997
1 Excerpt

Similar Papers

Loading similar papers…